Samar Dissoki

High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors.

Galith Abourbeh, Eyal Mishani, Alexander Levitzki, 2005, Journal of medicinal chemistry.

Fluorine-18 labeling of ML04 - : presently the most promising irreversible inhibitor candidate for visualization of EGFR in cancer

E. Mishani, Samar Dissoki, D. Laky, 2006 .

PET Molecular Imaging of Angiogenesis with a Multiple Tyrosine Kinase Receptor-Targeted Agent in a Rat Model of Myocardial Infarction

E. Mishani, Orit Jacobson, G. Abourbeh, 2015, Molecular Imaging and Biology.

Labeling approaches for the GE11 peptide, an epidermal growth factor receptor biomarker

A. Hagooly, E. Mishani, Samar Dissoki, 2011 .

Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors.

A. Levitzki, E. Mishani, Orit Jacobson, 2007, Nuclear medicine and biology.

Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET

C. Nanni, S. Fanti, P. Lollini, 2010, Molecular Imaging and Biology.

Modified PEG-anilinoquinazoline derivatives as potential EGFR PET agents

E. Mishani, Samar Dissoki, Hana Billauer, 2009 .

The effect of the [18F]-PEG group on tracer qualification of [4-(phenylamino)-quinazoline-6-YL]-amide moiety--an EGFR putative irreversible inhibitor.

A. Levitzki, E. Mishani, G. Abourbeh, 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.